HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

KY1220

destabilizes both beta-catenin and Ras proteins to promote their degradation in the treatment of cancer; structure in first source
Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results